Cargando…
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259246/ https://www.ncbi.nlm.nih.gov/pubmed/37313502 http://dx.doi.org/10.1093/noajnl/vdad061 |
| _version_ | 1785057622543564800 |
|---|---|
| author | Riviere-Cazaux, Cecile Lacey, Jean M Carlstrom, Lucas P Laxen, William J Munoz-Casabella, Amanda Hoplin, Matthew D Ikram, Samar Zubair, Abdullah Bin Andersen, Katherine M Warrington, Arthur E Decker, Paul A Kaufmann, Timothy J Campian, Jian L Eckel-Passow, Jeanette E Kizilbash, Sani H Tortorelli, Silvia Burns, Terry C |
| author_facet | Riviere-Cazaux, Cecile Lacey, Jean M Carlstrom, Lucas P Laxen, William J Munoz-Casabella, Amanda Hoplin, Matthew D Ikram, Samar Zubair, Abdullah Bin Andersen, Katherine M Warrington, Arthur E Decker, Paul A Kaufmann, Timothy J Campian, Jian L Eckel-Passow, Jeanette E Kizilbash, Sani H Tortorelli, Silvia Burns, Terry C |
| author_sort | Riviere-Cazaux, Cecile |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10259246 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102592462023-06-13 Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas Riviere-Cazaux, Cecile Lacey, Jean M Carlstrom, Lucas P Laxen, William J Munoz-Casabella, Amanda Hoplin, Matthew D Ikram, Samar Zubair, Abdullah Bin Andersen, Katherine M Warrington, Arthur E Decker, Paul A Kaufmann, Timothy J Campian, Jian L Eckel-Passow, Jeanette E Kizilbash, Sani H Tortorelli, Silvia Burns, Terry C Neurooncol Adv Brief Communication Oxford University Press 2023-05-11 /pmc/articles/PMC10259246/ /pubmed/37313502 http://dx.doi.org/10.1093/noajnl/vdad061 Text en © The Author(s) 2023. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Brief Communication Riviere-Cazaux, Cecile Lacey, Jean M Carlstrom, Lucas P Laxen, William J Munoz-Casabella, Amanda Hoplin, Matthew D Ikram, Samar Zubair, Abdullah Bin Andersen, Katherine M Warrington, Arthur E Decker, Paul A Kaufmann, Timothy J Campian, Jian L Eckel-Passow, Jeanette E Kizilbash, Sani H Tortorelli, Silvia Burns, Terry C Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas |
| title | Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas |
| title_full | Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas |
| title_fullStr | Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas |
| title_full_unstemmed | Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas |
| title_short | Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas |
| title_sort | cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for idh-mutant gliomas |
| topic | Brief Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259246/ https://www.ncbi.nlm.nih.gov/pubmed/37313502 http://dx.doi.org/10.1093/noajnl/vdad061 |
| work_keys_str_mv | AT rivierecazauxcecile cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT laceyjeanm cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT carlstromlucasp cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT laxenwilliamj cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT munozcasabellaamanda cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT hoplinmatthewd cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT ikramsamar cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT zubairabdullahbin cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT andersenkatherinem cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT warringtonarthure cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT deckerpaula cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT kaufmanntimothyj cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT campianjianl cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT eckelpassowjeanettee cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT kizilbashsanih cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT tortorellisilvia cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas AT burnsterryc cerebrospinalfluid2hydroxyglutarateasamonitoringbiomarkerforidhmutantgliomas |